2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°Á : 2024-07-13
±³À°ÀÏÀÚ : 2024-07-13
±³À°Àå¼Ò : ¼¿ï´ëÇб³º´¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ 1Ãþ ¼¼ºÈ¯¿¬±¸È¦
±³À°ÁÖÁ¦ : 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°ÁÂ
ÁÖÃÖ±â°ü : ´ëÇѳ»ºÐºñÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸
´ã´çÀÚ : ÀÓµ¿ÁØ
¿¬¶ôó : 02-3147-8022
À̸ÞÀÏ : ldj6026@catholic.ac.kr
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, ½Å°æ¿Ü°ú, ¾È°ú, ½Å°æ°ú
Âü¼®¿¹»óÀÎ : 70¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 20,000¿ø
ºñ°í ±³¼ö 20,000¿ø / °»ç ¹× PostDoc,¿¬±¸¿ø 10,000¿ø / Àü°øÀÇ, ´ëÇпø»ý ¹«·á
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 07¿ù 13ÀÏ ¼¼ºÈ¯¿¬±¸È¦ 09:00~09:30 2023 ÇÁ·Î¶ôƾ¼±Á¾ Áø·áÁöħ ¾÷µ¥ÀÌÆ® ±èº¸Çö(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 07¿ù 13ÀÏ ¼¼ºÈ¯¿¬±¸È¦ 09:30~10:00 ´Þ¶óÁø ¸»´Üºñ´ëÁõ Áø´Ü°ú °üÇØ ±âÁØ: IGF-1 vs. GH ±è¹Ì°æ(°è¸íÀÇ´ë)
±³À°½Ã°£ 07¿ù 13ÀÏ ¼¼ºÈ¯¿¬±¸È¦ 10:00~10:30 ¼Ò¾Æû¼Ò³âÀÇ ³úÇϼöü ¼±Á¾ °ü¸® ½ÇÀü °¡ÀÌµå ±èÀÚÇý(¿ï»êÀÇ´ë)
ÈÞ½Ä 07¿ù 13ÀÏ 10:30~10:50 ÈÞ½Ä ( )
±³À°½Ã°£ 07¿ù 13ÀÏ ¼¼ºÈ¯¿¬±¸È¦ 10:50~11:20 ³ëÀÎ ³úÇϼöü±â´ÉÀúÇÏÁõÀÇ Áø´Ü°ú Ä¡·á °È£Ã¶(Àü³²ÀÇ´ë)
±³À°½Ã°£ 07¿ù 13ÀÏ ¼¼ºÈ¯¿¬±¸È¦ 11:20~11:50 ÀÇÀÎ ºÎ½Å±â´ÉÀúÇÏÁõ Á¦´ë·Î ¾Ë±â ÀÓµ¿ÁØ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 07¿ù 13ÀÏ ¼¼ºÈ¯¿¬±¸È¦ 11:50~12:20 È£¸£¸ó Àå±â Ä¡·á ½Ã ³õÄ¡Áö ¸»¾Æ¾ß ÇÒ ³»°úÀû ¹®Á¦ ÀÌÁÖÈñ(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 07¿ù 13ÀÏ ¼¼ºÈ¯¿¬±¸È¦ 12:20~13:20 Role of Cabergoline in Acromegaly Áø»ó¿í(°æÈñÀÇ´ë)
±³À°½Ã°£ 07¿ù 13ÀÏ ¼¼ºÈ¯¿¬±¸È¦ 13:20~13:50 Between a Rock and a Hard Place: Surgery in Dopamine Agonist-treated Prolactinomas ¹®ÁÖÇü(¿¬¼¼ÀÇ´ë ½Å°æ¿Ü°ú)
±³À°½Ã°£ 07¿ù 13ÀÏ ¼¼ºÈ¯¿¬±¸È¦ 13:50~14:20 Pituitary Tumors Invading Cavernous Sinus: Surgery vs. Radiosurgery °øµÎ½Ä(¼º±Õ°üÀÇ´ë ½Å°æ¿Ü°ú)
±³À°½Ã°£ 07¿ù 13ÀÏ ¼¼ºÈ¯¿¬±¸È¦ 14:20~14:50 Balancing Salt and Water Following Surgery °È£(¼¿ïÀÇ´ë ½Å°æ¿Ü°ú)
ÈÞ½Ä 07¿ù 13ÀÏ 14:50~15:10 ÈÞ½Ä ( )
±³À°½Ã°£ 07¿ù 13ÀÏ ¼¼ºÈ¯¿¬±¸È¦ 15:10~15:40 À¯Áó ºÐºñ¸¦ ÁÖ¼Ò·Î ³»¿øÇÑ 13¼¼ ¿©ÀÚ ÀÌÀ±Á¤(¼¿ïÀÇ´ë ¼Ò¾Æû¼Ò³â°ú)
±³À°½Ã°£ 07¿ù 13ÀÏ ¼¼ºÈ¯¿¬±¸È¦ 15:40~16:10 ½Ã·Â ¹× ½Ã¾ßÀå¾Ö¸¦ ÁÖ¼Ò·Î ³»¿øÇÑ 64¼¼ ³²ÀÚ ¹ÚÁö¿ë(Àü³²ÀÇ´ë)
±âŸ 07¿ù 13ÀÏ ¼¼ºÈ¯¿¬±¸È¦ 16:10~16:40 Cushing ¹Î¼¼Èñ(¿ï»êÀÇ´ë)